The medical finding about how Oren Varkony died does not, by itself, determine whether the clinic or its staff acted negligently. An autopsy attributed the 36-year-old’s death to a hyaluronic-acid pulmonary embolism and classified it as an accident. His mother’s pending Dallas County lawsuit raises separate questions about warnings, evaluation and physician oversight, according to Dallas News.
Varkony died on September 3, 2025, hours after his fourth penis-filler session at AdvancedYOU Wellness Center. The autopsy reported material consistent with hyaluronic acid near the injection site and in small blood vessels in his lungs. Those findings describe the reported cause of death; they do not establish whether any particular person’s conduct caused it or fell below professional standards.
The dispute over earlier symptoms and oversight
The lawsuit alleges that after an earlier treatment Varkony reported swelling, numbness and a lump, and that clinic founder William Moore attributed the symptoms to needle and erection-related soft-tissue injury rather than the filler. It further alleges Varkony was not examined in person after reporting them. The complaint says Moore performed all four sessions despite not being licensed to practice medicine in Texas, and that the treatments lacked adequate warnings and physician supervision. These are allegations, not findings that the court has established.
The lawsuit also alleges that medical director Holly Barko was responsible for PhalloFILL protocols, delegation and supervision at the clinic. Moore told Dallas News that the defendants categorically deny the allegations and acted appropriately and responsibly. The case remains pending.
The FDA warning is broader than this case
The filler identified in the case coverage was Revanesse Versa+, whose FDA-authorized use is for treating facial wrinkles and folds—not penile augmentation, according to Dallas News. More generally, the FDA says it may not have reviewed dermal fillers for every body location. It also warns that unintended injection into a blood vessel can block blood flow and impair the blood supply to tissue. That general safety warning does not establish the cause of Varkony’s death or resolve the lawsuit’s allegations.
The regulatory distinction matters because authorization for one treatment site should not be read as FDA review of another. PhalloFILL’s website described its hyaluronic-acid penis fillers as safe, effective and reversible, while listing temporary swelling, tenderness and bruising as possible side effects, according to the lawsuit coverage. The dispute includes whether Varkony received an adequate explanation of risks specific to the procedure.
Delegation is another unresolved question
Texas treats penis-filler injections as the practice of medicine, while allowing a physician to perform them or authorize a properly trained person to do so. Texas’s January 2025 med-spa rules cover written protocols and physician-identification postings, according to a med-spa regulatory summary. Whether AdvancedYOU’s delegation and supervision met the applicable requirements is a question for the pending case, not something the autopsy findings answer.
